Hyperfine Appoints Kyla Pavlina, J.D., as Chief People Officer
Industry veteran brings extensive medtech and healthcare human resources leadership experience to the company
GUILFORD, CT – August 31, 2021 — Hyperfine Inc., creator of the first FDA-cleared portable magnetic resonance imaging (MRI) device, Swoop™, has appointed Kyla Pavlina, J.D., as chief people officer.
“We are thrilled to welcome Kyla as our chief people officer as we continue to expand our team to reach more patients and support ramping commercial growth,” said Hyperfine president and chief executive officer, Dave Scott. “Kyla’s specialized background, experience building strategic global talent pipelines and record of accomplishment in creating effective cultures make her a tremendous asset to Hyperfine as we continue our rapid hiring plans.”
Pavlina brings over 15 years of experience leading global organizational development, talent acquisition, compensation, labor law, and cross-functional teams to achieve business goals with talent. She will be responsible for all aspects of Hyperfine’s human capital assets and strategies.
“Hyperfine is changing the paradigm for MRI access across the globe, and that statement is as much about evolving technology as the human capabilities making that access possible,” said Pavlina. “I couldn’t be more excited to have a hand in bringing such an important diagnostic tool to so many people.”
Prior to Hyperfine, Pavlina served as the chief people officer at Mesa Biotech, Inc. (now Thermo Fisher Scientific), where she supervised a 1200% talent growth initiative over nine months, developed an equity plan, and re-designed and executed a company-wide benefits and bonus plan. She also served as vice president of human resources at SeaSpine, a medical device company developing treatments for spinal disorders, and was head of human resources at CrossFit, Inc. previously. Before transitioning into human resources, she leveraged her law degree as an attorney.
Pavlina holds a bachelor’s degree in international political science from Columbia University and a juris doctorate degree from Cleveland State University.
Pavlina joins the Hyperfine team following the recent appointments of Dave Scott as President and CEO, Scott Huennekens as Executive Chairman, and Alok Gupta as Chief Financial Officer.
Hyperfine was founded with a vision to save lives by making Magnetic Resonance Imaging (MRI) more accessible and affordable. Hyperfine’s portable Swoop™ system is the world’s first FDA-cleared bedside MRI system. Hyperfine was founded in 2014 by Jonathan Rothberg, Ph.D., a serial entrepreneur and the founder or co-founder of numerous other innovative companies, including CuraGen, 454 Life Sciences, Ion Torrent, RainDance Technologies, ClariFI, Quantum-Si, AI Therapeutics, Butterfly Network, 4Catalyzer, and 4Bionics. In 2015, Rothberg was awarded the National Medal of Technology and Innovation by President Obama for inventing and commercializing DNA sequencing.